Rajangam Kanya, President and Chief Medical (TASE:PMCN) and Development Officer at Senti Biosciences, Inc. (NASDAQ:SNTI), a micro-cap biotech company with a market capitalization of approximately $20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback